z-logo
Premium
Po‐Poster ‐ 28: Examination of gene expression in p53(+/−) mice exposed to low dose radiation using Affymetrix cDNA microarrays
Author(s) -
Morris D,
Knox D,
Lavoie J,
Lemon J,
Boreham D
Publication year - 2005
Publication title -
medical physics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 180
eISSN - 2473-4209
pISSN - 0094-2405
DOI - 10.1118/1.2031007
Subject(s) - dna microarray , complementary dna , gene expression , microarray , gene , biology , microbiology and biotechnology , microarray analysis techniques , dna damage , gene expression profiling , dna repair , gene chip analysis , dna , genetics
Gamma radiation acts via the indirect effect to damage cells by producing reactive oxygen species (ROS). These ROS are capable damaging macromolecules and, altering signal pathways and gene transcription. Cells have evolved enzymes and mechanisms to scavenge ROS and repair oxidative damage. Microarrays allow the survey of the gene transcription activity of thousands of genes simultaneously. Messenger RNA is extracted from cells, hybridized with the complementary DNA (cDNA) of a microarray chip, and examined with a chip reader. Affymetrix microarray chips have been produced by the CSCHAH in Winnipeg containing 26000 murine genes. Groups of female mice have been exposed to low dose whole body chronic gamma radiation exposures of 0,50,100, and 120 mGy, corresponding to 15,30,60, and 75 weeks, respectively. MRNA from mice brain tissue has been extracted, isolated, converted to cDNA and labeled. Gene expression in each irradiated mouse was compared to the pooled expression of the control mice. Analysis of gene expression levels are performed with microarray analytical software, Array Pro by Media Cybernetics, and powerful statistical software, BRB microarray tools. Differences in gene expressions, focusing on genes for cytokines, DNA repair mechanisms, immuno‐modulators, apoptosis pathways, and enzymatic anti‐oxidant systems, are being examined and will be reported.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here